First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas

Clinical trial NCT03188965 · COMPLETED

Trial details

NCT number: NCT03188965
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Non-Hodgkin's Lymphoma Mantle Cell Lymphoma

Start date: 2017-07-06
Primary completion: 2022-12-02
Enrollment: 229

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.